The Cannigma

NOVEMBER 1, 2023

Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains.

Topical 82

Topical Data Terpenes Cannabinoids 82

Canna Law Blog

OCTOBER 4, 2023

Under California law , operators of commercial websites that collect “personally identifiable information through the Internet about individual consumers residing in California who use or visit its commercial Web site” need a privacy policy. It’s more likely to affect hemp/cannabinoid companies that sell in e-commerce.

Policy 98

Policy Business Data Collective 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Canna Law Blog

OCTOBER 4, 2023

Under California law , operators of commercial websites that collect “personally identifiable information through the Internet about individual consumers residing in California who use or visit its commercial Web site” need a privacy policy. It’s more likely to affect hemp/cannabinoid companies that sell in e-commerce.

Policy 72

Policy Business Data Collective 72

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

CannaMD

JANUARY 6, 2021

Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.

Recreational 105

Recreational Marijuana Data Collective 105

Cannabis Law Report

FEBRUARY 2, 2022

– Flora’s research division, Flora Pharma, files USPTO provisional patent application on a cannabinoid-based formula. – Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA).

Cannabinoids 52

Cannabinoids Clinical Trials Events Cultivation 52

MedicalJane

JUNE 12, 2020

The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

OCTOBER 31, 2021

This study analyzes the components of vaporizer cartridges for 10 different metals and also collects aerosol mixtures from 13 randomly purchased commercially available cannabis cartridges from Washington State to compare their elemental profiles. Supporting Information. The Supporting Information is available free of charge at [link].

Concentrates 98

Concentrates Terpenes Oil Compliance 98

Cannabis Law Report

JUNE 25, 2021

These regulatory bodies work in conjunction with each other, and collectively share the responsibility of overseeing cannabis regulation across Canada. Regulatory Authorities share the collective responsibility of enforcement and compliance. Use of Non-controlled Cannabinoids in Food. Enforcement.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Veriheal

MAY 30, 2022

Our most recent data shows how cannabinoids via industrial hemp decreased the stress hormone cortisol as well as the inflammatory biomarker prostaglandin E2. He adds, “The initial data we have collected is essential should industrial hemp and its by-product be considered by the U.S. milligrams CBDA daily.

Hemp 101

Hemp Cannabinoids Concentrates Agriculture 101

TheAnswerPage

AUGUST 23, 2022

Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy? A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronic pain patients view the use of cannabis-based products for medicinal purposes.

Chronic Pain 98

Chronic Pain Medicine Collective Data 98

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. collecting items related to trains). Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 78

Sleep Cannabinoids Patients CBD 78

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.

Advocacy 96

Advocacy Patients Clinical Trials Education 96

Veriheal

SEPTEMBER 15, 2021

Descriptive Research: This type of research aims to do exactly what the name suggests, to describe and define the characteristics of the subject matter, such as cannabinoids, terpenes, and other compounds. . Non-Experimental Research: Observational study, or non-experimental research, focuses on analyzing data in its natural context.

Data 81

Data Collective Environment Cannabis 81

Otherside Farms

MAY 10, 2022

It is a synthetic cannabinoid that produces psychedelic effects to its users. THC-O is not an entirely natural cannabinoid. It’s one of many synthetic cannabinoids and does not occur on its own without human intervention. THC-O is also new to the market and does not have any long-term data. About THC-O. THC-O Gummies.

THC 98

THC Tincture Cannabinoids Vaping 98

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

MARCH 10, 2022

And recent data released by the USDA on the value of national hemp production in 2021 reveals that, despite challenges across the country, hemp remains a viable and valuable domestic crop. The USDA is keenly aware of the need for more data from the industry to develop more specific, data-driven policies in the future.

Hemp 52

Hemp Research and Development Supply Chain Data 52

Cannabis Law Report

AUGUST 9, 2021

The study will utilize Radicle Science’s data analytics platform and a virtual, direct-to-consumer model to deliver objective health outcome data across diverse populations and conditions. This randomized controlled trial will collect data on 13 U.S. Nutritional Outlook.

Hemp 105

Hemp CBD Legalization Edibles 105

Cannabis Law Report

NOVEMBER 22, 2021

Emyria was listed on the ASX last year, just before Australia was plunged into the global COVID-19 pandemic, and has been progressing with trials of a synthetic cannabinoid targeting mental health which it hopes to have registered domestically and in the American market. Read more [link].

Clinical Trials 52

Clinical Trials Treatment Medicine Cannabinoids 52

The Cannigma

NOVEMBER 12, 2023

The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.

Data 105

Data Tincture Research and Development Food 105

Veriheal

JUNE 30, 2023

The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. The basis of the CSMAS argument stems from the findings of the 2022 Summit on Cannabinoids in College Athletics.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

AUGUST 18, 2022

The laboratory researched the fine print of every state’s rules for hemp sampling, THC potency, cannabinoid content, residual solvents, pesticides, mycotoxins, heavy metals, and microbiology. With that research, they created elaborate matrices to compare each mandate. Source: [link].

Compliance 52

Compliance Compliance Hemp Research and Development 52

Puff Puff Post

MARCH 10, 2020

About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. For more information, visit www.inmedpharma.com. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Furthermore, THC and CBD may have a synergistic effect.

Data 89

Data Chronic Pain Sleep Patients 89

Cannabis Law Report

NOVEMBER 15, 2021

As we collectively analyze and respond to emerging issues in the cannabis industry, we will continue to be the preeminent voice in cannabis regulatory policy.”. Public Health and Data Monitoring. Cannabinoid Hemp. Social and Economic Equity. Medical Use and Research. Lab Testing and Product Safety. Public Education.

Compliance 98

Compliance Compliance Topical Programs 98

Canna Law Blog

FEBRUARY 21, 2020

Last week, the Food Standard Agency (“ FSA ”), the agency responsible for protecting public health in relation to food in England, Wales and Northern Ireland (collectively, the “UK”), cleared a path for the sale of CBD-infused food for the next 12 months. The EFSA guidance on cannabinoids strongly echoes the U.S.

Food 94

Food CBD Legalization Hemp 94

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

FEBRUARY 15, 2022

They offer a standardized process for making cannabis powder, highlight instruments, and demand high quality data. A liquid nanoemulsion is the gold standard for food and beverage formulations infused with cannabinoids like THC or CBD. Cannabis powder is a collection of microparticles in a micrometer or micron size range.

Research and Development 52

Research and Development Trichome Digestion Edibles 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108